卒中后肌少症相关研究进展
Advances in Research Related to Post-Stroke Sarcopenia
DOI: 10.12677/ACM.2024.143808, PDF,   
作者: 陈晓晗, 李小倩, 高 飞*：西安医学院第一附属医院，陕西 西安
关键词: 卒中；肌少症；发生机制；干预；综述；Stroke； Sarcopenia； Mechanisms； Intervention； Review
摘要: 肌少症是一种以骨骼肌质量降低、力量下降、和(或)躯体功能减退为特征的临床综合征，可导致老年人生活能力下降、跌倒、死亡等不良后果。脑卒中是老年人常见的急性疾病，不仅病死率高，而且致残率也很高。老年人群由于代谢、神经功能等各方面因素的影响，更易出现脑卒中后的后遗症，其中肌少症就是一种常见的情况。脑卒中后发生肌少症的机制尚不明确，但与多种因素有关，本文就脑卒中后继发肌少症的发病机制及相关影响因素做一综述。
Abstract: Sarcopenia is a clinical syndrome characterised by reduced skeletal muscle mass, decreased strength, and/or reduced somatic function, which can lead to adverse outcomes such as reduced ability to live, falls, and death in older adults. Stroke is a common acute disease in the elderly, which not only has a high morbidity and mortality rate, but also has a high disability rate. The elderly population is more prone to post-stroke sequelae due to various factors such as metabolism and neurological function, among which sarcopenia is a common condition. The mechanism of post-stroke sarcopenia is not clear, but it is related to a variety of factors. In this article, we review the pathogenesis of stroke combined with sarcopenia and the related influencing factors.
文章引用：陈晓晗, 李小倩, 高飞. 卒中后肌少症相关研究进展[J]. 临床医学进展, 2024, 14(3): 1049-1055. https://doi.org/10.12677/ACM.2024.143808

参考文献

[1] Collaborators GLRoS (2018) Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. The New England Journal of Medicine, 379, 2429-2437. [Google Scholar] [CrossRef] 
[2] Wang, W.Z., Jiang, B., Sun, H.X., Ru, X.J., Sun, D.L., Wang, L.H., et al. (2017) Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480687 Adults. Circulation, 135, 759-771. [Google Scholar] [CrossRef] 
[3] Cesari, M., Kritchevsky, S.B., Baumgartner, R.N., et al. (2005) Sarcopenia, Obesity, and Inflammation—Results from the Trial of Angiotensin Converting Enzyme Inhibi-tion and Novel Cardiovascular Risk Factors Study. The American Journal of Clinical Nutrition, 82, 428-434. [Google Scholar] [CrossRef] [PubMed]
[4] 赵英培, 段丽梅, 许志平, 等. 肌少症指数评估老年危重症患者营养不良及其对预后的影响[J]. 中国老年学杂志, 2023, 43(1): 70-74.
[5] Cruz Jentoft, A.J., Bahat, G., Bauer, J., et al. (2019) Sarcopenia: Revised European Consensus on Definition and Diagnosis. Age Ageing, 48, 601. [Google Scholar] [CrossRef] [PubMed]
[6] Rosenberg, I.H. (1997) Sarcopenia: Origins and Clinical Relevance. The Journal of Nutrition, 127, 990s-991s. [Google Scholar] [CrossRef] 
[7] Domenico, A. (2020) Imaging of Sarcopenia: Old Evidence and New Insights. European Radiology, 30, 2199-2208. [Google Scholar] [CrossRef] [PubMed]
[8] Solomon, A. and Bouloux, P. (2006) Endocrine Therapies for Sarcopenia in Older Men. British Journal of Hospital Medicine (London), 67, 477-481. [Google Scholar] [CrossRef] [PubMed]
[9] Li, X.Y., Xu, L. and Xu, Z.X. (2021) The Diagnostic and Prognostic Performance of Lp-PLA2 in Acute Ischemic Stroke. Medicina Clínica, 156, 437-443. [Google Scholar] [CrossRef] [PubMed]
[10] Li, X.B., Wu, F., Jiang, C., et al. (2021) Novel Peripheral Blood Cell Ratios: Effective 3-Month Post-Mechanical Thrombectomy Prognostic Biomarkers for Acute Ischemic Stroke Pa-tients. Journal of Clinical Neuroscience, 89, 56-64. [Google Scholar] [CrossRef] [PubMed]
[11] Rory, D.S., Jesisca, J. and Hartanto, Y.B. (2019) Neutro-phil-to-Lympocyte Ratio as a Prognostic Factor in Acute Ischemic Stroke Patients. Journal of the Neurological Sciences, 405, 94. [Google Scholar] [CrossRef] 
[12] 陈礼荣, 叶晓莉. 老年脑卒中病人肌少症与卒中后吞咽功能障碍的相关性研究[J]. 实用老年医学, 2023, 37(9): 947-950+955.
[13] Wakabayashi, H. and Sakuma, K. (2014) Rehabilitation Nutrition for Sarcopenia with Disability: A Combination of both Rehabilitation and Nutrition Care Man-agement. Journal of Cachexia, Sarcopenia and Muscle, 5, 269-277. [Google Scholar] [CrossRef] [PubMed]
[14] Wade, D.T. and Hewer, R.L. (1987) Motor Loss and Swallowing Difficulty after Stroke: Frequency, Recovery, and Prognosis. Acta Neurologica Scandinavica, 76, 50-54. [Google Scholar] [CrossRef] [PubMed]
[15] Vemmos, K., Ntaios, G., Spengos, K., et al. (2011) As-sociation between Obesity and Mortality after Acute First-Ever Stroke: The Obesity-Stroke Paradox. Stroke, 42, 30-36. [Google Scholar] [CrossRef] 
[16] Yoo, S.H., Kim, J.S., Kwon, S.U., et al. (2008) Undernu-trition as a Predictor of Poor Clinical Outcomes in Acute Ischemic Stroke Patients. Archives of Neurology, 65, 39-43. [Google Scholar] [CrossRef] [PubMed]
[17] Sullivan, D.H., Sun, S. and Walls, R.C. (1999) Protein-Energy Undernutrition among Elderly Hospitalized Patients: A Prospective Study. JAMA, 281, 2013-2019. [Google Scholar] [CrossRef] [PubMed]
[18] Kortebein, P., Ferrando, A., Lombeida, J., et al. (2007) Effect of 10 Days of Bed Rest on Skeletal Muscle in Healthy Older Adults. JAMA, 297, 1769-1774. [Google Scholar] [CrossRef] [PubMed]
[19] Bernhardt, J., Dewey, H., Thrift, A., et al. (2004) Inactive and Alone: Physical Activity within the First 14 Days of Acute Stroke Unit Care. Stroke, 35, 1005-1009. [Google Scholar] [CrossRef] 
[20] Arasaki, K., Igarashi, O., Ichikawa, Y., et al. (2006) Reduction in the Motor Unit Number Estimate (MUNE) after Cerebral Infarction. Journal of the Neurological Sciences, 250, 27-32. [Google Scholar] [CrossRef] [PubMed]
[21] Knops, M., Werner, C.G., Scherbakov, N., et al. (2013) Investigation of Changes in Body Composition, Metabolic Profile and Skeletal Muscle Functional Capacity in Ischemic Stroke Patients: The Rationale and Design of the Body Size in Stroke Study (BoSSS). Journal of Cachexia, Sarcopenia and Muscle, 4, 199-207. [Google Scholar] [CrossRef] [PubMed]
[22] Springer, J., Schust, S., Peske, K., et al. (2014) Catabolic Signal-ing and Muscle Wasting after Acute Ischemic Stroke in Mice: Indication for a Strokespecific Sarcopenia. Stroke, 45, 3675-3683. [Google Scholar] [CrossRef] 
[23] Liguori, I., Russo, G., Curcio, F., et al. (2018) Oxidative Stress, Aging, and Diseases. Clinical Interventions in Aging, 13, 757-772. [Google Scholar] [CrossRef] 
[24] Kalyani, R.R., Corriere, M. and Ferrucci, L. (2014) Age-Related and Disease-Related Muscle LOSS: The Effect of Diabetes, Obesity, and Other Diseases. The Lancet Diabetes & Endocri-nology, 2, 819-829. [Google Scholar] [CrossRef] 
[25] Sehiaffino, S., Dyar, K.A., Ciciliot, S., et al. (2013) Mecha-nisms Regulating Skeletal Muscle Growth and Atrophy. FEBS Journal, 280, 4294-4314. [Google Scholar] [CrossRef] [PubMed]
[26] Dirks, M.L., et al. (2016) One Week of Bed Rest Leads to Substantial Muscle Atrophy and Induces Whole-Body Insulin Resistance in the Absence of Skeletal Muscle Lipid Accumulation. Diabetes, 65, 2862-2875. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, L., Guo, Q., Feng, B.L., et al. (2019) A Cross-Sectional Study of the Association between Arterial Stiffness and Sarcopenia in Chinese Community Dwelling Elderly Using the Asian Working Group for Sarcopenia Criteria. The Journal of Nutrition Health Aging, 23, 195-201. [Google Scholar] [CrossRef] [PubMed]
[28] Pan, N., Lu, L., Li, M., et al. (2017) Xyloketal B Alleviates Cere-bral Infarction and Neurologic Deficits in a Mouse Stroke Model by Suppressing the ROS/TLR4/NF-κB Inflammatory Signaling Pathway. Acta Pharmacologica Sinica, 38, 1236-1247. [Google Scholar] [CrossRef] [PubMed]
[29] Beyer, I., Mets, T. and Bautmans, I. (2012) Chronic Low-Grade Inflammation and Age-Related Sarcopenia. Current Opinion in Clinical Nutrition & Metabolic Care, 15, 12-22. [Google Scholar] [CrossRef] 
[30] Wood, H. (2018) An Alarmin’ Inflammatory Response after Stroke. Nature Reviews Neurology, 14, 252-253. [Google Scholar] [CrossRef] [PubMed]
[31] Zhou, Y.Z., Chen, P.J. and Xiao, W.H. (2018) Mechanism of the Occurrence of Sarcopenia in the Elderly. Acta Physiologica Sinica, 70, 445-454.
[32] 刘莹, 谭寅凤, 于苗, 等. 老年恶性肿瘤肌少症发生率及影响因素[J]. 中国老年学杂志, 2024, 44(2): 281-284.
[33] Lathuilière, A., Mareschal, J. and Graf, C.E. (2019) How to Prevent Loss of Muscle Mass and Strength among Older People in Neuro-Rehabilitation? Nutrients, 11, 881. [Google Scholar] [CrossRef] [PubMed]
[34] Yabluchanskiy, A. and Tsitouras, P.D. (2019) Is Testosterone Replacement Therapy in Older Men Effective and Safe? Drugs Aging, 36, 981-989. [Google Scholar] [CrossRef] [PubMed]
[35] Guillet, C., Prod’homme, M., Balage, M., et al. (2004) Impaired Anabolic Response of Muscle Protein Synthesis Is Associated with S6K1 Dysregulation in Elderly Humans. The FASEB Journal, 18, 1586-1587. [Google Scholar] [CrossRef] [PubMed]
[36] Resnick, S.M., Matsumoto, A.M., StephensShields, A.J., et al. (2017) Testosterone Treatment and Cognitive Function in Older Men with Low Testosterone and Age-Associated Memory Im-pairment. JAMA, 317, 717-727. [Google Scholar] [CrossRef] [PubMed]
[37] Goisser, S., Kob, R., Sieber, C.C., et al. (2019) Diagnosis and Therapy of Sarcopenia—An Update. Internist (Berl), 60, 141-148. [Google Scholar] [CrossRef] [PubMed]
[38] Talar, K., Hernandez-Belmonte, A., Vetrovsky, T., et al. (2021) Benefits of Resistance Training in Early and Late Stages of Frailty and Sarcopenia: A Systematic Review and Me-ta-Analysis of Randomized Controlled Studies. Journal of Clinical Medicine, 10, Article No. 1630. [Google Scholar] [CrossRef] [PubMed]
[39] Huang, L.T. and Wang, J.H. (2021) The Therapeutic Intervention of Sex Steroid Hormones for Sarcopenia. Frontiers in Medicine (Lausanne), 8, Article ID: 739251. [Google Scholar] [CrossRef] [PubMed]
[40] Bartke, A. (2019) Growth Hormone and Aging: Updated Review. World Journal of Men’s Health, 37, 19-30. [Google Scholar] [CrossRef] [PubMed]

为你推荐